<DOC>
	<DOC>NCT01426386</DOC>
	<brief_summary>This trial investigates the effects of several doses of FE 999049 in women undergoing IVF/ICSI (in-vitro fertilisation/intracytoplasmic sperm injection) treatment.</brief_summary>
	<brief_title>A Dose-response Trial Using rFSH FE 999049 in Women Undergoing IVF/ICSI Treatment</brief_title>
	<detailed_description />
	<mesh_term>Infertility</mesh_term>
	<criteria>Women diagnosed with tubal infertility, unexplained infertility, infertility related to endometriosis stage I/II or with partners diagnosed with male factor infertility Women eligible for IVF (invitro fertilisation) and/or ICSI (intracytoplasmic sperm injection) treatment Women aged 1837 years Women with body mass index (BMI) of 18.532.0 kg/m2 Women with polycystic ovary syndrome (PCOS) associated with anovulation, endometriosis stage III/IV Women with history of recurrent miscarriage Women with contraindications to controlled ovarian stimulation with gonadotropins Women with three or more controlled ovarian stimulation cycles</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>37 Years</maximum_age>
	<verification_date>June 2013</verification_date>
</DOC>